Ironwood Pharmaceuticals (IRWD) Competitors

$8.09
-0.01 (-0.12%)
(As of 08:57 AM ET)

IRWD vs. LGND, MNKD, DVAX, INVA, ZNTL, OPK, CYRX, GERN, IGMS, and LXRX

Should you be buying Ironwood Pharmaceuticals stock or one of its competitors? The main competitors of Ironwood Pharmaceuticals include Ligand Pharmaceuticals (LGND), MannKind (MNKD), Dynavax Technologies (DVAX), Innoviva (INVA), Zentalis Pharmaceuticals (ZNTL), OPKO Health (OPK), Cryoport (CYRX), Geron (GERN), IGM Biosciences (IGMS), and Lexicon Pharmaceuticals (LXRX). These companies are all part of the "pharmaceutical preparations" industry.

Ironwood Pharmaceuticals vs.

Ironwood Pharmaceuticals (NASDAQ:IRWD) and Ligand Pharmaceuticals (NASDAQ:LGND) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, community ranking, analyst recommendations, earnings and institutional ownership.

In the previous week, Ligand Pharmaceuticals had 2 more articles in the media than Ironwood Pharmaceuticals. MarketBeat recorded 4 mentions for Ligand Pharmaceuticals and 2 mentions for Ironwood Pharmaceuticals. Ligand Pharmaceuticals' average media sentiment score of 0.68 beat Ironwood Pharmaceuticals' score of 0.48 indicating that Ligand Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ironwood Pharmaceuticals
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ligand Pharmaceuticals
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ligand Pharmaceuticals received 27 more outperform votes than Ironwood Pharmaceuticals when rated by MarketBeat users. Likewise, 69.92% of users gave Ligand Pharmaceuticals an outperform vote while only 61.04% of users gave Ironwood Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
Ironwood PharmaceuticalsOutperform Votes
503
61.04%
Underperform Votes
321
38.96%
Ligand PharmaceuticalsOutperform Votes
530
69.92%
Underperform Votes
228
30.08%

Ligand Pharmaceuticals has a net margin of 37.80% compared to Ironwood Pharmaceuticals' net margin of -226.37%. Ligand Pharmaceuticals' return on equity of 11.98% beat Ironwood Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Ironwood Pharmaceuticals-226.37% -185.45% 21.00%
Ligand Pharmaceuticals 37.80%11.98%10.27%

91.3% of Ligand Pharmaceuticals shares are held by institutional investors. 13.1% of Ironwood Pharmaceuticals shares are held by insiders. Comparatively, 10.4% of Ligand Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Ligand Pharmaceuticals has lower revenue, but higher earnings than Ironwood Pharmaceuticals. Ironwood Pharmaceuticals is trading at a lower price-to-earnings ratio than Ligand Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ironwood Pharmaceuticals$442.74M2.86-$1.00B-$6.51-1.24
Ligand Pharmaceuticals$131.31M9.57$52.15M$2.7525.82

Ironwood Pharmaceuticals has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Comparatively, Ligand Pharmaceuticals has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500.

Ironwood Pharmaceuticals presently has a consensus price target of $19.80, suggesting a potential upside of 144.44%. Ligand Pharmaceuticals has a consensus price target of $116.33, suggesting a potential upside of 63.85%. Given Ironwood Pharmaceuticals' higher probable upside, research analysts plainly believe Ironwood Pharmaceuticals is more favorable than Ligand Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ironwood Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Ligand Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Ligand Pharmaceuticals beats Ironwood Pharmaceuticals on 12 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IRWD vs. The Competition

MetricIronwood PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.30B$6.50B$4.91B$7.48B
Dividend YieldN/A3.09%2.97%3.96%
P/E Ratio-1.2417.41259.1720.61
Price / Sales2.86298.122,392.9280.27
Price / CashN/A29.1346.6734.58
Price / Book-3.675.624.664.30
Net Income-$1.00B$139.69M$103.69M$213.92M
7 Day Performance5.88%-1.24%-0.26%1.26%
1 Month Performance-6.68%-9.33%-6.30%-4.19%
1 Year Performance-23.37%-3.96%7.96%7.75%

Ironwood Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LGND
Ligand Pharmaceuticals
4.9287 of 5 stars
$69.89
+2.0%
$116.33
+66.5%
-8.1%$1.24B$131.31M25.4158Upcoming Earnings
MNKD
MannKind
1.5976 of 5 stars
$4.16
+1.2%
$8.00
+92.3%
+5.8%$1.13B$198.96M-83.20411
DVAX
Dynavax Technologies
4.3863 of 5 stars
$11.76
-0.7%
$25.00
+112.6%
+4.4%$1.55B$232.28M-195.97408Positive News
INVA
Innoviva
1.4867 of 5 stars
$15.17
+1.6%
N/A+28.5%$959.20M$310.46M6.96112News Coverage
Positive News
High Trading Volume
ZNTL
Zentalis Pharmaceuticals
1.0519 of 5 stars
$12.57
-3.3%
$38.57
+206.9%
-45.3%$891.97MN/A-2.77124Positive News
OPK
OPKO Health
4.7156 of 5 stars
$1.25
+1.6%
$3.73
+198.0%
-15.8%$871.24M$863.50M-5.003,930Upcoming Earnings
CYRX
Cryoport
1.3051 of 5 stars
$16.11
+0.3%
$18.63
+15.6%
-26.7%$791.97M$233.26M-7.321,170Upcoming Earnings
Gap Up
GERN
Geron
3.2734 of 5 stars
$3.50
-6.2%
$5.33
+52.4%
+35.1%$1.91B$240,000.00-10.61141Gap Up
IGMS
IGM Biosciences
3.9078 of 5 stars
$7.70
+14.1%
$17.44
+126.6%
-28.9%$452.68M$2.13M-1.60224
LXRX
Lexicon Pharmaceuticals
0.9637 of 5 stars
$1.61
-5.8%
$5.00
+210.6%
-32.5%$421.07M$1.20M-2.01285Analyst Report

Related Companies and Tools

This page (NASDAQ:IRWD) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners